Equities

Beijing Luzhu Biotechnology Co Ltd

Beijing Luzhu Biotechnology Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)26.50
  • Today's Change-0.300 / -1.12%
  • Shares traded200.00
  • 1 Year change+29.27%
  • Beta--
Data delayed at least 15 minutes, as of May 13 2024 07:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Beijing Luzhu Biotechnology Co Ltd is a China-based company principally engaged in drug discovery, research and development and commercialization. The Company is also engaged in out-licensing human vaccines and therapeutic biologics. Its products under clinical development include recombinant herpes zoster vaccine LZ901, and antibody injection products K3 and K193. Its LZ901 is mainly used to prevent herpes zoster caused by varicella zoster virus in adults aged 50 and above. The Company operates in the domestic market and overseas markets.

  • Revenue in HKD (TTM)0.00
  • Net income in HKD-269.86m
  • Incorporated2001
  • Employees133.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Biocytogen Pharmaceuticals Beijng Co Ltd775.88m-414.45m3.89bn1.07k--4.58--5.02-1.04-1.041.952.130.273216.215.74727,837.90-14.59---18.88--70.59---53.42--1.24-21.300.4077--34.28--36.38------
CK Life Sciences Intl (Holdings) Inc5.32bn17.25m4.37bn1.93k254.191.0438.570.82160.00180.00180.55380.43590.47282.964.742,755,038.000.15321.110.2111.4330.7630.520.32412.420.85120.87960.586159.000.89360.3407-86.93-42.010.2784--
Jiangsu Recbio Technology Co Ltd0.00-619.00m4.44bn472.00--3.80-----1.29-1.290.002.420.00----0.00-25.47---30.68----------2.33--0.378------20.86------
Ocumension Therapeutics266.63m-411.02m4.72bn444.00--1.48--17.71-0.6334-0.63340.41074.570.0783.612.12600,517.40-12.03-38.78-13.21-41.4758.6062.30-154.16-975.823.72--0.0451--54.99--5.68--319.66--
Alphamab Oncology236.77m-227.91m5.05bn435.00--2.79--21.31-0.237-0.2370.24671.880.10280.770519.34544,292.60-9.90-18.72-11.69-21.9474.75---96.26-415.555.55--0.1333--31.12--35.35---13.12--
Shandong Boan Biotechnology Co Ltd668.97m-129.20m5.19bn813.00--3.64--7.77-0.2537-0.25371.312.800.27321.352.53822,838.40-5.28---7.02--66.16---19.31--0.8383-7.470.2491--19.80--64.02------
Consun Pharmaceutical Group Ltd2.80bn849.06m5.20bn3.13k5.991.315.561.861.061.063.514.840.49812.089.10896,431.6015.1312.0422.5719.2574.1974.5530.3724.892.62--0.115541.5310.717.0314.8811.01--18.43
Microport NeuroTech Ltd-100.00bn-100.00bn5.40bn571.00------------------------------------------------21.61--768.73------
Beijing Luzhu Biotechnology Co Ltd0.00-269.86m5.43bn133.00--4.91-----1.35-1.350.005.46------0.00----------------6.41--0.0185------65.62------
ImmuneOnco Biopharmaceuticls Shanghi Inc-100.00bn-100.00bn5.46bn---------------------------------------------------28.25--5.82------
Ascentage Pharma Group International240.24m-1.00bn5.83bn583.00--89.21--24.28-3.54-3.540.8510.22530.08332.382.22412,077.70-34.73-44.93-52.82-57.0486.2487.68-417.02-976.101.42-15.030.9622--5.85100.76-4.84--2.82--
Sihuan Pharmaceutical Holdings Group Ltd2.01bn-58.46m5.88bn2.87k--1.23--2.92-0.0063-0.00630.21660.51410.15720.81014.72701,100.60-2.18-6.85-3.34-9.1069.6475.81-13.85-36.231.35-2.630.1863---14.70-8.6097.23--0.9325--
Qyuns Therapeutics Co Ltd0.00-549.51m6.02bn331.00--18.87-----2.47-2.470.001.44------0.00----------------1.64-69.520.5349-------70.28------
New Horizon Health Ltd1.47bn119.72m6.47bn1.04k59.032.0041.524.390.23960.23963.237.060.45362.162.081,678,816.003.67--3.99--88.74--8.10--10.50--0.1305--259.54--97.40------
Shanghai Fudan-Zhangjiang Bio-Pharm. Co875.79m110.59m6.78bn948.0020.840.9091--7.740.10750.10750.83172.460.28521.441.62923,828.003.597.034.359.0591.4092.1712.5917.263.94568.370.006239.16-17.502.78-21.28-0.632620.490.00
Tong Ren Tang Technologies Co Ltd7.33bn638.73m7.22bn4.10k11.310.96885.260.98540.49870.49875.725.820.52120.98355.681,787,504.007.647.6812.1012.3242.0443.5014.6516.112.37--0.144339.9413.046.011.25-2.73-22.260.0178
Data as of May 13 2024. Currency figures normalised to Beijing Luzhu Biotechnology Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
SSgA Funds Management, Inc.as of 04 Apr 20241.60k0.00%
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.